Autopsy report · NCT00930189

Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Undefined”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2, Phase 3
Sponsor: Asociación para Evitar la Ceguera en México
Sponsor type: University, hospital or other
Conditions: Subfoveal Choroidal Neovascularization
Interventions: intravitreal injection of ranibizumab; intravitreal injection of triamcinolone; photodynamic therapy
Participants: 0
Sites: 1
Countries: Mexico

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.